Risk Factors for Depression in Patients Undergoing Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 7, 2014, Pages 946-950

  Artherholt, Samantha B ^a,b   Hong, Fangxin ^c,d   Berry, Donna L ^c,e   Fann, Jesse R ^a,b,f,g  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CANCER CARE ALLIANCE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Bone marrow transplantation; Depression; Hematopoietic cell transplantation; Hematopoietic stem cell transplantation; Quality of life

Indexed keywords

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; COMPUTER; DEMOGRAPHY; DEPRESSION; DISTRESS SYNDROME; EARLY DIAGNOSIS; EMOTION; EMOTIONAL FUNCTION; EMPLOYMENT STATUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PAIN INTENSITY SCALE; PATIENT CARE; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT REFERRAL; QUALITY OF LIFE; RATING SCALE; RISK FACTOR; SYMPTOM DISTRESS SCALE; ALLOTRANSPLANTATION; MIDDLE AGED; PSYCHOLOGY; YOUNG ADULT;

ADULT; AGED; DEPRESSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84902115975     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.03.010     Document Type: Article

References (38)

1. Pasquini M.C., Wang Z. Current use and outcome of hematopoietic stem cell transplantation. CIBMTR Summary Slides 2013, Available at: http://www.cibmtr.org. Accessed October 23, 2013.
2. Horowitz M.M. Uses and growth of hematopoietic cell transplantation. Thomas' hematopoietic cell transplantation: stem cell transplantation 2009, Wiley-Blackwell, Oxford, UK. 4th ed. F.R. Appelbaum, K.G. Blume, S.J. Forman, R.S. Negrin (Eds.).
3. Mosher C.E., Redd W.H., Rini C.M., et al. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 2009, 18:113-127.
4. Sun C.L., Francisco L., Baker K.S., et al. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 2011, 118:4723-4731.
5. Massie M.J. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004, 32:57-71.
6. Syrjala K.L., Langer S.L., Abrams J.R., et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004, 291:2335-2343.
7. Loberiza F.R., Rizzo J.D., Bredeson C.N., et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002, 20:2118-2126.
8. Fann J.R., Berry D.L., Wolpin S., et al. Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology 2009, 18:14-22.
9. Neitzert C., Ritvo P., Dancey J., et al. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplantation 1998, 22:409-422.
10. Mosher C.E., DuHamel K.N., Rini C., et al. Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer 2011, 19:1357-1365.
11. Hoodin F., Zhao L., Carey J., et al. Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant 2013, 19:1493-1497.
12. Colleoni M., Mandala M., Peruzzotti G., et al. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000, 356:1326-1327.
13. Kendler K.S., Neale M.C., MacLean C.J., et al. Smoking and major depression: a causal analysis. Arch Gen Psychiatry 1993, 50:36-43.
14. Kiecolt-Glaser J.K., Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002, 53:873-876.
15. Schulz R., Drayer R.A., Rollman B.L. Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry 2002, 52:205-225.
16. Wulsin L.R., Vaillant G.E., Wells V.E. A systematic review of the mortality of depression. Psychosom Med 1999, 61:6-17.
17. Pinquart M., Duberstein P.R. Depression and cancer mortality: a meta-analysis. Psychol Med 2010, 40:1797-1810.
18. Grulke N., Larbig W., Kachele H., Bailer H. Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation. Psychooncology 2008, 17:480-487.
19. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: distress management. Available at: Accessed August 27, 2013. https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf.
20. American College of Surgeons, Commission on Cancer. Cancer program standards 2012: ensuring patient-centered care. Available from: Accessed August 27, 2013. http://www.sgmc.org/sites/www/Uploads/COC%20Program%20Stds%202012.pdf.
21. Berry D.L., Blumenstein B.A., Halpenny B., et al. Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol 2011, 29:1029-1035.
22. Berry D.L., Trigg L.J., Lober W.B., et al. Computerized symptom and quality-of-life assessment for patients with cancer, part I: development and pilot testing. Oncol Nurs Forum 2004, 31:E75-E83.
23. Dockrey M.R., Lober W.B., Wolpin S.E., et al. Distributed health assessment and intervention research software framework. AMIA Annu Symp Proc 2005, 2005:940.
24. Karras B.T., Wolpin S., Lober W.B., et al. Electronic Self-Report Assessment-Cancer (ESRA-C): working towards an integrated survey system. Stud Health Technol Inform 2006, 122:514-518.
25. Tariman J.D., Berry D.L., Halpenny B., et al. Validation and testing of the Acceptability E-scale for Web-based patient-reported outcomes in cancer care. Appl Nurs Res 2011, 24:53-58.
26. McCorkle R., Young K. Development of a symptom distress scale. Cancer Nurs 1978, 1:373-378.
27. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
28. Grulke N., Albani C., Bailer H. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30. Bone Marrow Transplant 2012, 47:473-482.
29. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
30. Lowe B., Kroenke K., Herzog W., Grafe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord 2004, 81:61-66.
31. Lowe B., Unutzer J., Callahan C.M., et al. Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Med Care 2004, 42:1194-1201.
32. Pinto-Meza A., Serrano-Blanco A., Penarrubia M.T., et al. Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone?. J Gen Intern Med 2005, 20:738-742.
33. Thekkumpurath P., Walker J., Butcher I., et al. Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item Patient Health Questionnaire. Cancer 2011, 117:218-227.
34. Whooley M.A., Avins A.L., Miranda J., Browner W.S. Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med 1997, 12:439-445.
35. Henkel V., Mergl R., Coyne J.C., et al. Screening for depression in primary care: will one or two items suffice?. Eur Arch Psychiatry Clin Neurosci 2004, 254:215-223.
36. Ryan D.A., Gallagher P., Wright S., Cassidy E.M. Sensitivity and specificity of the Distress Thermometer and a two-item depression screen (Patient Health Questionnaire-2) with a "help" question for psychological distress and psychiatric morbidity in patients with advanced cancer. Psychooncology 2012, 21:1275-1284.
37. Wells K.J., Booth-Jones M., Jacobsen P.B. Do coping and social support predict depression and anxiety in patients undergoing hematopoietic stem cell transplantation?. J Psychosoc Oncol 2009, 27:297-315.
38. de Boer A.G., Bruinvels D.J., Tytgat K.M., et al. Employment status and work-related problems of gastrointestinal cancer patients at diagnosis: a cross-sectional study. BMJ Open 2011, 1:e000190.